NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 142 filers reported holding NEVRO CORP in Q1 2016. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,878,000 | -26.5% | 27,200 | -3.2% | 0.18% | -65.8% |
| Q3 2017 | $2,554,000 | +7.2% | 28,100 | -12.2% | 0.54% | -8.5% |
| Q2 2017 | $2,382,000 | -31.3% | 32,000 | -13.5% | 0.59% | -43.2% |
| Q1 2017 | $3,467,000 | -4.6% | 37,000 | -26.0% | 1.04% | -64.2% |
| Q4 2016 | $3,633,000 | -27.2% | 50,000 | +4.6% | 2.90% | +48.6% |
| Q3 2016 | $4,990,000 | -7.9% | 47,800 | -34.9% | 1.95% | -16.2% |
| Q2 2016 | $5,420,000 | -35.8% | 73,475 | -41.2% | 2.33% | +84.2% |
| Q4 2015 | $8,439,000 | +56.9% | 125,000 | +7.8% | 1.26% | -65.7% |
| Q3 2015 | $5,378,000 | -39.9% | 115,927 | -30.4% | 3.68% | +41.6% |
| Q2 2015 | $8,947,000 | +231.0% | 166,450 | +195.1% | 2.60% | +162.9% |
| Q1 2015 | $2,703,000 | – | 56,400 | – | 0.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |